Our Research

At Aggamin, we are committed to advancing the field of biotechnology through innovative research and development. Our primary focus is the development of groundbreaking therapies for vascular diseases, with a particular emphasis on preeclampsia — a serious condition affecting 5% of pregnancies, resulting in significant health costs to the U.S. healthcare system.

Focused on Preeclampsia

Our lead program is dedicated to finding a solution to preeclampsia. This life-threatening condition can impact both the mother and child, and current treatment options are limited. By focusing our efforts on understanding and addressing this disease, we aim to provide new hope for affected families and improve overall maternal health.

Innovative Therapies for Vascular Diseases

In addition to preeclampsia, Aggamin is exploring a range of vascular diseases to develop treatments that improve quality of life and reduce healthcare burdens. Through rigorous research and collaboration with experts in the field, we strive to make meaningful progress toward more effective and accessible treatments for these conditions.

Stay tuned for updates on our research, as we continue to push the boundaries of science to deliver breakthrough therapies that can change lives.

FAQ

Explore common questions about our mission and programs.
What is preeclampsia and why is it significant?

Preeclampsia is a life-threatening condition affecting 5% of pregnancies worldwide. Aggamin's research targets this condition to mitigate its impact on mothers and babies.

Why is research on preeclampsia important?

Research on preeclampsia is crucial to develop solutions that can save lives, improve pregnancy outcomes, and enhance maternal and infant health globally.

How does Aggamin leverage science to fight preeclampsia?

Aggamin utilizes cutting-edge science to develop innovative therapies that can effectively combat preeclampsia and improve the well-being of pregnant women and their babies.

How does Aggamin contribute to healthcare systems?

Aggamin's innovative therapies aim to improve patient outcomes, transform healthcare systems, and address unmet needs in vascular health.

Join Us in Advancing Healthcare

Stay informed on our groundbreaking research and clinical trials. Together, we can make a difference in the fight against vascular diseases.